(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

VACINA COM BASE EM POXVÍRUS RECOMBINANTE CONTRA VÍ-RUS SARS-COV-2

Em AnáliseInvention PatentPCT · US2021020119

Application data

Number

112022016992

Type

Invention Patent

Filing

02/26/2021

Publication

10/25/2022

PCT

US2021020119

Progress at the INPI

  1. Filing02/26/21
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 02/26/2021. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 10/25/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

THE GOVERNORS OF THE UNIVERSITY OF ALBERTA

CA

TONIX PHARMA LIMITED

IE

See this company's full portfolio

Inventors

D. E. (pessoa física)

CA

R. N. (pessoa física)

CA

S. G. (pessoa física)

US

S. L. (pessoa física)

US

Technical data

Priority claims

US

62/981,997 · 02/26/2020

US

63/114,514 · 11/16/2020

Abstract

VACINA COM BASE EM POXVÍRUS RECOMBINANTE CONTRA VÍRUS SARS-COV-2.A invenção refere-se em vários aspectos ao poxvírus recombinante que compreende um ácido nucleico que codifica uma proteína do vírus SARS-CoV-2, a métodos para produção de tais viroses e o uso de tais vírus. As poxviroses recombinantes são bem adequadas, entre outras, como vacinas virais protetoras contra o vírus SARS-CoV-2.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

10/25/2022

RPI 2703

Alteração de dados cadastrais

#1.1

09/06/2022

RPI 2696

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.